Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA3354681
Max Phase: Preclinical
Molecular Formula: C28H42N12O5S
Molecular Weight: 658.79
Molecule Type: Protein
Associated Items:
ID: ALA3354681
Max Phase: Preclinical
Molecular Formula: C28H42N12O5S
Molecular Weight: 658.79
Molecule Type: Protein
Associated Items:
Canonical SMILES: N=C(N)NCCC[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(N)=O)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)c1nc2ccccc2s1
Standard InChI: InChI=1S/C28H42N12O5S/c29-15(6-3-11-35-27(31)32)23(43)38-18(14-21(30)41)26(45)40-13-5-9-19(40)24(44)37-17(8-4-12-36-28(33)34)22(42)25-39-16-7-1-2-10-20(16)46-25/h1-2,7,10,15,17-19H,3-6,8-9,11-14,29H2,(H2,30,41)(H,37,44)(H,38,43)(H4,31,32,35)(H4,33,34,36)/t15-,17-,18-,19-/m0/s1
Standard InChI Key: PUQNZQBNSIATMI-WNHJNPCNSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Protein | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 658.79 | Molecular Weight (Monoisotopic): 658.3122 | AlogP: -1.83 | #Rotatable Bonds: 17 |
Polar Surface Area: 301.38 | Molecular Species: BASE | HBA: 10 | HBD: 10 |
#RO5 Violations: 2 | HBA (Lipinski): 17 | HBD (Lipinski): 14 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 11.59 | CX Basic pKa: 12.07 | CX LogP: -3.50 | CX LogD: -8.26 |
Aromatic Rings: 2 | Heavy Atoms: 46 | QED Weighted: 0.04 | Np Likeness Score: -0.41 |
1. Duchêne D, Colombo E, Désilets A, Boudreault PL, Leduc R, Marsault E, Najmanovich R.. (2014) Analysis of subpocket selectivity and identification of potent selective inhibitors for matriptase and matriptase-2., 57 (23): [PMID:25387268] [10.1021/jm5015633] |
Source(1):